GMR Agenda debuts the 2nd Intestinal Microecology and Disease Research Transformation Theory

Theme Session

Opening speech

Zhao Guoping, Academician of Chinese Academy of Sciences, Researcher of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

Clinical research findings on regulating intestinal microecology and enhancing tumor immunotherapy

Qin Huanlong, Dean of the Tenth People's Hospital Affiliated to Tongji University

Topic to be determined

Ouyi

Treatment 2 diabetes gut and plural sets of conversion Studies

Liping Zhao, Academician of the American Academy of Microbiology, Distinguished Professor of Microbiology, School of Life Sciences and Technology, Shanghai Jiao Tong University

From gut microbiota to medical translation ( FMT treatment, early screening diagnosis)

Research on NASH- Microbe Interaction Relationship and Clinical Translation Research

Wu Jian, Professor of School of Basic Medicine, Fudan University, Zhongshan Hospital, Fudan University, Double-appointed Professor of Gastroenterology

Study on the relationship between intestinal microbiome and liver cirrhosis

Lu Lungen, Director, Professor, Doctoral Supervisor, Department of Gastroenterology, First People's Hospital Affiliated to Shanghai Jiaotong University

New mechanism of intestinal flora metabolites to improve non-alcoholic fatty liver disease

Jiangao Fan, Director, Professor, Doctoral Supervisor, Department of Gastroenterology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine

Clinical practice of FMT in IBD inflammatory bowel disease

Wu Jianjiong, Director of Inflammatory Bowel Disease Diagnosis and Treatment Center, Shanghai Jiaotong University

Topic to be determined

Qihui

Research and transformation of intestinal microbial multiomics in tumor immune precision medicine

Liu Jie, Director of the Institute of Digestive Diseases, Fudan University, Director of the Department of Gastroenterology, Affiliated Huashan Hospital; Professor, Department of Immunology, Fudan University

Analysis of clinical efficacy of washing bacteria transplantation in the treatment of autism

He Xingxiang, Chief Physician, Professor, and Secretary of the Party Committee of the Gastroenterology Department of the First Affiliated Hospital of Guangdong Pharmaceutical University

Intestinal flora FMT and anti-tumor drug treatment

Li Suyi, Director of Cancer Nutrition and Metabolism Therapy Department ( Western District ) and Director of Cancer Chemotherapy Department, The First Affiliated Hospital of University of Science and Technology of China

Topic to be determined

Good deeds

Accelerate the development and industrialization of intestinal microecological treatment drugs

Research on Bacteria as Targeted Anti-tumor Living Biological Drugs

Hua Zichun, Professor of Nanjing University College of Student Sciences, Dean of the School of Biopharmaceuticals, China Pharmaceutical University

Development and industrialization of intestinal microecological treatment drugs targeting mental diseases

Duan Yunfeng, Dean of Beijing Huayuan Institute of Biotechnology

Gut microbiota as a new target for immunotherapy

Zhu Yongliang, Chairman and Chief Scientist of Presen Gene

Experience sharing of IND application for intestinal bacteria transplantation drugs

Tan Yan, CEO / Co-founder of Shenzhen Weijun Biotechnology Co.

Round-table discussion: How can China accelerate the improvement of the micro-ecological pharmaceutical industry chain in line with international standards?

Bin Xiang, CEO of

New drug discovery and clinical development of small molecule drugs for regulating intestinal microecology

Ma Zhenkun, founder and CEO of Dannuo Pharmaceuticals

International case sharing: The key factors of intestinal microbial treatment from scientific research to industrialization

Dr.